| ■ 영문 제목 : Global Cancer Supportive Care Market 2023-2027
|
 | ■ 상품코드 : IRTNTR41301-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 1월
■ 페이지수 : 175
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의약품
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,375,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사의 시장 조사 보고서는 세계의 암 지지 요법 시장 규모가 2022년부터 2027년 사이에 6,563.92백만 달러에 이르며, 예측 기간 동안 CAGR 4.62% 확대될 것으로 전망하고 있습니다. 또한 본 조사 자료는 세계의 암 지지 요법 시장을 다방면으로 조사 및 분석하여, 개요, 시장 현황, 시장 규모, Five Force 분석, 치료 분야별 (화학 요법 유발성 빈혈, 화학 요법 유발성 호중구 감소증, 암 통증, CINV, 기타) 분석, 유통 채널별 (병원 약국, 드럭 스토어 및 소매 약국, 온라인 프로바이더) 분석, 고객 현황, 지역별 (북미, 유럽, 아시아, 기타 지역, 미국, 영국, 독일, 중국, 캐나다) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 보고서는 Acacia Pharma Group Plc, Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co. 등의 기업 정보가 포함되어 있습니다.
・개요
・시장 현황
・시장 규모 및 예측
・과거 시장 규모
・Five Force 분석
・세계의 암 지지 요법 시장 규모 : 치료 분야별
- 화학 요법 유발성 빈혈 치료의 시장 규모
- 화학 요법 유발성 호중구 감소증 치료의 시장 규모
- 암 통증 치료의 시장 규모
- CINV 치료의 시장 규모
- 기타 치료 분야의 시장 규모
・세계의 암 지지 요법 시장 규모 : 유통 채널별
- 병원 약국 채널의 시장 규모
- 드럭 스토어 및 소매 약국 채널의 시장 규모
- 온라인 프로바이더 채널의 시장 규모
・고객 현황
・세계의 암 지지 요법 시장 규모 : 지역별
- 북미의 암 지지 요법 시장 규모
- 유럽의 암 지지 요법 시장 규모
- 아시아의 암 지지 요법 시장 규모
- 기타 지역의 암 지지 요법 시장 규모
- 미국의 암 지지 요법 시장 규모
- 영국의 암 지지 요법 시장 규모
- 독일의 암 지지 요법 시장 규모
- 중국의 암 지지 요법 시장 규모
- 캐나다의 암 지지 요법 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Cancer Supportive Care Market 2023-2027
Technavio has been monitoring the cancer supportive care market and is forecast to grow by $6,563.92 mn during 2022-2027, accelerating at a CAGR of 4.62% during the forecast period. Our report on the cancer supportive care market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, many side effects associated with the cancer treatment, and untapped potential in developing countries.
Technavio’s cancer supportive care market is segmented as below:
By Distribution Channel
• Hospitals pharmacies
• Drug stores and retail pharmacies
• Online providers
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the advent of biosimilars in cancer-associated treatment as one of the prime reasons driving the cancer supportive care market growth during the next few years. Also, outsourcing of biosimilars manufacturing activities and adoption of various strategies will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cancer supportive care market covers the following areas:
• Cancer supportive care market sizing
• Cancer supportive care market forecast
• Cancer supportive care market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer supportive care market vendors that include Acacia Pharma Group Plc, Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson, Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, RELIEF THERAPEUTICS Holding SA, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the cancer supportive care market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapeutic Area
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global cancer supportive care market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global cancer supportive care market 2017 – 2021 ($ million)
o 4.2 Therapeutic area Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Therapeutic area Segment 2017 – 2021 ($ million)
o 4.3 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Therapeutic Area
o 6.1 Market segments
o Exhibit 30: Chart on Therapeutic Area – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapeutic Area – Market share 2022-2027 (%)
o 6.2 Comparison by Therapeutic Area
o Exhibit 32: Chart on Comparison by Therapeutic Area
o Exhibit 33: Data Table on Comparison by Therapeutic Area
o 6.3 Chemotherapy-induced anemia – Market size and forecast 2022-2027
o Exhibit 34: Chart on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
o 6.4 Chemotherapy-induced neutropenia – Market size and forecast 2022-2027
o Exhibit 38: Chart on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
o 6.5 Cancer pain – Market size and forecast 2022-2027
o Exhibit 42: Chart on Cancer pain – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Cancer pain – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Cancer pain – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Cancer pain – Year-over-year growth 2022-2027 (%)
o 6.6 CINV – Market size and forecast 2022-2027
o Exhibit 46: Chart on CINV – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on CINV – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on CINV – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on CINV – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Therapeutic Area
o Exhibit 54: Market opportunity by Therapeutic Area ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 55: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 56: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 57: Chart on Comparison by Distribution Channel
o Exhibit 58: Data Table on Comparison by Distribution Channel
o 7.3 Hospitals pharmacies – Market size and forecast 2022-2027
o Exhibit 59: Chart on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
o 7.4 Drug stores and retail pharmacies – Market size and forecast 2022-2027
o Exhibit 63: Chart on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
o 7.5 Online providers – Market size and forecast 2022-2027
o Exhibit 67: Chart on Online providers – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Online providers – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Online providers – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Online providers – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 71: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 77: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 93: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 97: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 101: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 105: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 109: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 113: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 120: Amgen Inc. – Overview
o Exhibit 121: Amgen Inc. – Product / Service
o Exhibit 122: Amgen Inc. – Key offerings
o 12.4 Baxter International Inc.
o Exhibit 123: Baxter International Inc. – Overview
o Exhibit 124: Baxter International Inc. – Business segments
o Exhibit 125: Baxter International Inc. – Key news
o Exhibit 126: Baxter International Inc. – Key offerings
o Exhibit 127: Baxter International Inc. – Segment focus
o 12.5 Bayer AG
o Exhibit 128: Bayer AG – Overview
o Exhibit 129: Bayer AG – Business segments
o Exhibit 130: Bayer AG – Key news
o Exhibit 131: Bayer AG – Key offerings
o Exhibit 132: Bayer AG – Segment focus
o 12.6 Daiichi Sankyo Co. Ltd.
o Exhibit 133: Daiichi Sankyo Co. Ltd. – Overview
o Exhibit 134: Daiichi Sankyo Co. Ltd. – Business segments
o Exhibit 135: Daiichi Sankyo Co. Ltd. – Key news
o Exhibit 136: Daiichi Sankyo Co. Ltd. – Key offerings
o Exhibit 137: Daiichi Sankyo Co. Ltd. – Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 138: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 139: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 142: F. Hoffmann La Roche Ltd. – Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 143: GlaxoSmithKline Plc – Overview
o Exhibit 144: GlaxoSmithKline Plc – Business segments
o Exhibit 145: GlaxoSmithKline Plc – Key offerings
o Exhibit 146: GlaxoSmithKline Plc – Segment focus
o 12.9 Heron Therapeutics Inc.
o Exhibit 147: Heron Therapeutics Inc. – Overview
o Exhibit 148: Heron Therapeutics Inc. – Product / Service
o Exhibit 149: Heron Therapeutics Inc. – Key news
o Exhibit 150: Heron Therapeutics Inc. – Key offerings
o 12.10 Johnson and Johnson
o Exhibit 151: Johnson and Johnson – Overview
o Exhibit 152: Johnson and Johnson – Business segments
o Exhibit 153: Johnson and Johnson – Key news
o Exhibit 154: Johnson and Johnson – Key offerings
o Exhibit 155: Johnson and Johnson – Segment focus
o 12.11 Kyowa Kirin Co. Ltd.
o Exhibit 156: Kyowa Kirin Co. Ltd. – Overview
o Exhibit 157: Kyowa Kirin Co. Ltd. – Product / Service
o Exhibit 158: Kyowa Kirin Co. Ltd. – Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 159: Merck and Co. Inc. – Overview
o Exhibit 160: Merck and Co. Inc. – Business segments
o Exhibit 161: Merck and Co. Inc. – Key news
o Exhibit 162: Merck and Co. Inc. – Key offerings
o Exhibit 163: Merck and Co. Inc. – Segment focus
o 12.13 Novartis AG
o Exhibit 164: Novartis AG – Overview
o Exhibit 165: Novartis AG – Business segments
o Exhibit 166: Novartis AG – Key offerings
o Exhibit 167: Novartis AG – Segment focus
o 12.14 Purdue Pharma LP
o Exhibit 168: Purdue Pharma LP – Overview
o Exhibit 169: Purdue Pharma LP – Product / Service
o Exhibit 170: Purdue Pharma LP – Key offerings
o 12.15 Sanofi SA
o Exhibit 171: Sanofi SA – Overview
o Exhibit 172: Sanofi SA – Business segments
o Exhibit 173: Sanofi SA – Key news
o Exhibit 174: Sanofi SA – Key offerings
o Exhibit 175: Sanofi SA – Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 176: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 177: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 178: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 179: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 180: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 181: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 182: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 183: Teva Pharmaceutical Industries Ltd. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 184: Inclusions checklist
o Exhibit 185: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 186: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 187: Research methodology
o Exhibit 188: Validation techniques employed for market sizing
o Exhibit 189: Information sources
o 13.5 List of abbreviations
o Exhibit 190: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Therapeutic Area
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global cancer supportive care market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Therapeutic area Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Therapeutic Area – Market share 2022-2027 (%)
Exhibits31: Data Table on Therapeutic Area – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapeutic Area
Exhibits33: Data Table on Comparison by Therapeutic Area
Exhibits34: Chart on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Cancer pain – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Cancer pain – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Cancer pain – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Cancer pain – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on CINV – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on CINV – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on CINV – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on CINV – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapeutic Area ($ million)
Exhibits55: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits56: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Distribution Channel
Exhibits58: Data Table on Comparison by Distribution Channel
Exhibits59: Chart on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Online providers – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Online providers – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Online providers – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Online providers – Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Distribution Channel ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Amgen Inc. – Overview
Exhibits121: Amgen Inc. – Product / Service
Exhibits122: Amgen Inc. – Key offerings
Exhibits123: Baxter International Inc. – Overview
Exhibits124: Baxter International Inc. – Business segments
Exhibits125: Baxter International Inc. – Key news
Exhibits126: Baxter International Inc. – Key offerings
Exhibits127: Baxter International Inc. – Segment focus
Exhibits128: Bayer AG – Overview
Exhibits129: Bayer AG – Business segments
Exhibits130: Bayer AG – Key news
Exhibits131: Bayer AG – Key offerings
Exhibits132: Bayer AG – Segment focus
Exhibits133: Daiichi Sankyo Co. Ltd. – Overview
Exhibits134: Daiichi Sankyo Co. Ltd. – Business segments
Exhibits135: Daiichi Sankyo Co. Ltd. – Key news
Exhibits136: Daiichi Sankyo Co. Ltd. – Key offerings
Exhibits137: Daiichi Sankyo Co. Ltd. – Segment focus
Exhibits138: F. Hoffmann La Roche Ltd. – Overview
Exhibits139: F. Hoffmann La Roche Ltd. – Business segments
Exhibits140: F. Hoffmann La Roche Ltd. – Key news
Exhibits141: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits143: GlaxoSmithKline Plc – Overview
Exhibits144: GlaxoSmithKline Plc – Business segments
Exhibits145: GlaxoSmithKline Plc – Key offerings
Exhibits146: GlaxoSmithKline Plc – Segment focus
Exhibits147: Heron Therapeutics Inc. – Overview
Exhibits148: Heron Therapeutics Inc. – Product / Service
Exhibits149: Heron Therapeutics Inc. – Key news
Exhibits150: Heron Therapeutics Inc. – Key offerings
Exhibits151: Johnson and Johnson – Overview
Exhibits152: Johnson and Johnson – Business segments
Exhibits153: Johnson and Johnson – Key news
Exhibits154: Johnson and Johnson – Key offerings
Exhibits155: Johnson and Johnson – Segment focus
Exhibits156: Kyowa Kirin Co. Ltd. – Overview
Exhibits157: Kyowa Kirin Co. Ltd. – Product / Service
Exhibits158: Kyowa Kirin Co. Ltd. – Key offerings
Exhibits159: Merck and Co. Inc. – Overview
Exhibits160: Merck and Co. Inc. – Business segments
Exhibits161: Merck and Co. Inc. – Key news
Exhibits162: Merck and Co. Inc. – Key offerings
Exhibits163: Merck and Co. Inc. – Segment focus
Exhibits164: Novartis AG – Overview
Exhibits165: Novartis AG – Business segments
Exhibits166: Novartis AG – Key offerings
Exhibits167: Novartis AG – Segment focus
Exhibits168: Purdue Pharma LP – Overview
Exhibits169: Purdue Pharma LP – Product / Service
Exhibits170: Purdue Pharma LP – Key offerings
Exhibits171: Sanofi SA – Overview
Exhibits172: Sanofi SA – Business segments
Exhibits173: Sanofi SA – Key news
Exhibits174: Sanofi SA – Key offerings
Exhibits175: Sanofi SA – Segment focus
Exhibits176: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits177: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits178: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits179: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits180: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits181: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits182: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits183: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits184: Inclusions checklist
Exhibits185: Exclusions checklist
Exhibits186: Currency conversion rates for US$
Exhibits187: Research methodology
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Information sources
Exhibits190: List of abbreviations
|
| ※본 조사보고서 [세계의 암 지지 요법 시장 (2023년~2027년)] (코드 : IRTNTR41301-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 암 지지 요법 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
